Global and Region Gene Therapies for Cancer Treatment Market Demand & Opportunity Outlook 2022-2028

  • REPORT SUMMARY
  • TABLE OF CONTENTS
  • Gene therapy is the therapeutic delivery of nucleic acid into a patient's cells as a drug to treat disease. Research in gene therapy for cancer is currently focused in multiple areas, including genetically engineered viruses that directly kill cancer cells, gene transfer to alter the abnormal functioning of cancer cells, and immunotherapy (which includes CAR T-cell therapy), which helps the immune system better find and kill.

    In the last several years, global market of Gene Therapies for Cancer Treatment developed rapidly, with an average growth rate of 199%. In 2018, global revenue of Gene Therapies for Cancer Treatment is 445 million USD. The rising prevalence rate of cancer has been a huge challenge for the global economies as the disease leads to high rate of mortality and economic losses. The current treatment options available come with many drawbacks such as severe side effects and relapse of cancer. These factors have led to high investment in the R&D for development of various novel therapies with cancer gene therapy being one of the major ones of them.The classification of Gene Therapies for Cancer Treatment includes Gene Induced Immunotherapy, Oncolytic Virotherapy, Gene Transfer, and most of Gene Therapies for Cancer Treatment is Gene Induced Immunotherapy, the proportion of Biopsy in 2018 is about 78%.ene Therapies for Cancer Treatment is widely used in Hospital, Clinic and other. The most proportion of Gene Therapies for Cancer Treatment is used in Hospital, and the proportion is about 68.3% in 2018.

    The report details the trend, potential and market size of Gene Therapies for Cancer Treatment market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.

    The first part (Chapter1-7) mainly covers the qualitative analysis of Gene Therapies for Cancer Treatmentmarket, defines the market attractiveness level of Gene Therapies for Cancer Treatment market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.

    The second part (Chapter8-12), based on the segmentation of Gene Therapies for Cancer Treatment industry, describes the types of Gene Therapies for Cancer Treatment market, the applications of major players and the market size, and deeply analyzes the current situation of the global Gene Therapies for Cancer Treatment market and the development prospects and opportunities of Gene Therapies for Cancer Treatment industry.

    The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.

    As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Gene Therapies for Cancer Treatment market in Chapter 13.

    By Player:

    • Company 1

    • Company 2

    • Company 3

    • Company 4

    • Company 5

    • Company 6

    • Company 7

    • Company 8

    • Company 9

    • Company 10

    By Type:

    • Type 1

    • Type 2

    • Type 3

    By End-User:

    • Application 1

    • Application 2

    • Application 3

    By Geography:

    • United States

    • Europe

    • China

    • Japan

    • India

    • South Korea

  • TABLE OF CONTENT

    1 Introduction

    • 1.1 Market Definition

    • 1.2 Market Segment Analysis

    • 1.3 Market Size 2022

    • 1.4 Gene Therapies for Cancer Treatment Market Outlook: Forecast for 2022 - 2028

    • 1.5 Pricing Analysis

    2 Executive Summary

    3 Gene Therapies for Cancer Treatment Market Lineage Outlook

    • 3.1 Parent Market Outlook

    • 3.2 Related/Ancillary Market Outlook

    • 3.3 Penetration & Growth Prospect Mapping, 2022

    4 Market Analysis Tools: Porter's Five Forces

    • 4.1 Supplier Power

    • 4.2 Buyer Power

    • 4.3 Substitution Threat

    • 4.4 Threat of New Entrants

    • 4.5 Competitive Rivalry

    5 Gene Therapies for Cancer Treatment Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)

    • 5.1 Political/Legal Landscape

    • 5.2 Economic Landscape

    • 5.3 Social Landscape

    • 5.4 Technology Landscape

    6 Gene Therapies for Cancer Treatment Market - Value Chain Analysis

    • 6.1 Industry's Value Chain Analysis

    • 6.2 Product Life Cycle

    • 6.3 User Perspective Analysis

    7 Region and Country-wise Gene Therapies for Cancer Treatment Market Analysis and Outlook to 2022

    • 7.1 Global Gene Therapies for Cancer Treatment Consumption (2017-2022)

    • 7.2 United States Gene Therapies for Cancer Treatment Consumption (2017-2022)

    • 7.3 Europe Gene Therapies for Cancer Treatment Consumption (2017-2022)

    • 7.4 China Gene Therapies for Cancer Treatment Consumption (2017-2022)

    • 7.5 Japan Gene Therapies for Cancer Treatment Consumption (2017-2022)

    • 7.6 India Gene Therapies for Cancer Treatment Consumption (2017-2022)

    • 7.7 South Korea Gene Therapies for Cancer Treatment Consumption (2017-2022)

    8 Region and Country-wise Gene Therapies for Cancer Treatment Market Analysis and Outlook to 2028

    • 8.1 Global Gene Therapies for Cancer Treatment Consumption Forecast (2022-2028)

    • 8.2 United States Gene Therapies for Cancer Treatment Consumption Forecast (2022-2028)

    • 8.3 Europe Gene Therapies for Cancer Treatment Consumption Forecast (2022-2028)

    • 8.4 China Gene Therapies for Cancer Treatment Consumption Forecast (2022-2028)

    • 8.5 Japan Gene Therapies for Cancer Treatment Consumption Forecast (2022-2028)

    • 8.6 India Gene Therapies for Cancer Treatment Consumption Forecast (2022-2028)

    • 8.7 South Korea Gene Therapies for Cancer Treatment Consumption Forecast (2022-2028)

    9 Global Gene Therapies for Cancer Treatment Market Outlook by Types and Applications to 2022

    • 9.1 Global Gene Therapies for Cancer Treatment Consumption and Growth Rate by Type (2017-2022)

      • 9.1.1 Global Type 1 Consumption and Growth Rate (2017-2022)

      • 9.1.2 Global Type 2 Consumption and Growth Rate (2017-2022)

      • 9.1.3 Global Type 3 Consumption and Growth Rate (2017-2022)

    • 9.2 Global Gene Therapies for Cancer Treatment Consumption and Growth Rate by Application (2017-2022)

      • 9.2.1 Global Application 1 Consumption and Growth Rate (2017-2022)

      • 9.2.2 Global Application 2 Consumption and Growth Rate (2017-2022)

      • 9.2.3 Global Application 3 Consumption and Growth Rate (2017-2022)

    10 Global Gene Therapies for Cancer Treatment Market Outlook by Types and Applications to 2028

    • 10.1 Global Gene Therapies for Cancer Treatment Consumption Forecast and Growth Rate by Type (2022-2028)

      • 10.1.1 Global Type 1 Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.2 Global Type 2 Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.3 Global Type 3 Consumption Forecast and Growth Rate (2022-2028)

    • 10.2 Global Gene Therapies for Cancer Treatment Consumption Forecast and Growth Rate by Application (2022-2028)

      • 10.2.1 Global Application 1 Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.2 Global Application 2 Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.3 Global Application 3 Consumption Forecast and Growth Rate (2022-2028)

    11 Global Gene Therapies for Cancer Treatment Import and Export Analysis (Top 5 Countries)

    • 11.1 Global Gene Therapies for Cancer Treatment Import by Region (Top 5 Countries) (2017-2028)

    • 11.2 Global Gene Therapies for Cancer Treatment Export by Region (Top 5 Countries) (2017-2028)

    12 Coronavirus Disease (COVID-19) Impact

    • 12.1 Industry Impact Analysis

    • 12.2 Gene Therapies for Cancer Treatment Market Outlook to 2028 - COVID-19 Affected Forecasts

    13 Competition Matrix

    • 13.1 Target Markets

    • 13.2 Comprehensive Analysis of Products in Competitive Markets

    14 Global Gene Therapies for Cancer Treatment Market Competitive Analysis

    • 14.1 Company 1

      • 14.1.1 Company 1 Company Details

      • 14.1.2 Company 1 Gene Therapies for Cancer Treatment Sales, Price, Value and Gross Profit (2017-2022)

      • 14.1.3 Company 1 Gene Therapies for Cancer Treatment Product and Service

    • 14.2 Company 2

      • 14.2.1 Company 2 Company Details

      • 14.2.2 Company 2 Gene Therapies for Cancer Treatment Sales, Price, Value and Gross Profit (2017-2022)

      • 14.2.3 Company 2 Gene Therapies for Cancer Treatment Product and Service

    • 14.3 Company 3

      • 14.3.1 Company 3 Company Details

      • 14.3.2 Company 3 Gene Therapies for Cancer Treatment Sales, Price, Value and Gross Profit (2017-2022)

      • 14.3.3 Company 3 Gene Therapies for Cancer Treatment Product and Service

    • 14.4 Company 4

      • 14.4.1 Company 4 Company Details

      • 14.4.2 Company 4 Gene Therapies for Cancer Treatment Sales, Price, Value and Gross Profit (2017-2022)

      • 14.4.3 Company 4 Gene Therapies for Cancer Treatment Product and Service

    • 14.5 Company 5

      • 14.5.1 Company 5 Company Details

      • 14.5.2 Company 5 Gene Therapies for Cancer Treatment Sales, Price, Value and Gross Profit (2017-2022)

      • 14.5.3 Company 5 Gene Therapies for Cancer Treatment Product and Service

    • 14.6 Company 6

      • 14.6.1 Company 6 Company Details

      • 14.6.2 Company 6 Gene Therapies for Cancer Treatment Sales, Price, Value and Gross Profit (2017-2022)

      • 14.6.3 Company 6 Gene Therapies for Cancer Treatment Product and Service

    • 14.7 Company 7

      • 14.7.1 Company 7 Company Details

      • 14.7.2 Company 7 Gene Therapies for Cancer Treatment Sales, Price, Value and Gross Profit (2017-2022)

      • 14.7.3 Company 7 Gene Therapies for Cancer Treatment Product and Service

    • 14.8 Company 8

      • 14.8.1 Company 8 Company Details

      • 14.8.2 Company 8 Gene Therapies for Cancer Treatment Sales, Price, Value and Gross Profit (2017-2022)

      • 14.8.3 Company 8 Gene Therapies for Cancer Treatment Product and Service

    • 14.9 Company 9

      • 14.9.1 Company 9 Company Details

      • 14.9.2 Company 9 Gene Therapies for Cancer Treatment Sales, Price, Value and Gross Profit (2017-2022)

      • 14.9.3 Company 9 Gene Therapies for Cancer Treatment Product and Service

    • 14.10 Company 10

      • 14.10.1 Company 10 Company Details

      • 14.10.2 Company 10 Gene Therapies for Cancer Treatment Sales, Price, Value and Gross Profit (2017-2022)

      • 14.10.3 Company 10 Gene Therapies for Cancer Treatment Product and Service

    15 Appendix


    TABLE OF CHARTS

    • Table Definition of Gene Therapies for Cancer Treatment

    • Figure Gene Therapies for Cancer Treatment Picture

    • Table Global Gene Therapies for Cancer Treatment Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global Gene Therapies for Cancer Treatment Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global Gene Therapies for Cancer Treatment Market: Year-over-year Growth 2022 - 2028 (%)

    • Table Parent Market Analysis

    • Figure Parent Market Price

    • Table Related/Ancillary Market Outlook Analysis

    • Table Supplier Power Analysis

    • Table Buyer Power Analysis

    • Table Substitution Threat Analysis

    • Table Threat of New Entrants Analysis

    • Table Competitive Rivalry Analysis

    • Figure Global Gene Therapies for Cancer Treatment Consumption by Country (2017-2022)

    • Figure United States Gene Therapies for Cancer Treatment Consumption and Growth Rate (2017-2022)

    • Table Europe Gene Therapies for Cancer Treatment Consumption and Growth Rate (2017-2022)

    • Figure China Gene Therapies for Cancer Treatment Consumption and Growth Rate (2017-2022)

    • Figure Japan Gene Therapies for Cancer Treatment Consumption and Growth Rate (2017-2022)

    • Figure India Gene Therapies for Cancer Treatment Consumption and Growth Rate (2017-2022)

    • Figure South Korea Gene Therapies for Cancer Treatment Consumption and Growth Rate (2017-2022)

    • Figure Global Gene Therapies for Cancer Treatment Consumption Forecast by Country (2022-2028)

    • Figure United States Gene Therapies for Cancer Treatment Consumption Forecast and Growth Rate (2022-2028)

    • Table Europe Gene Therapies for Cancer Treatment Consumption Forecast and Growth Rate (2022-2028)

    • Figure China Gene Therapies for Cancer Treatment Consumption Forecast and Growth Rate (2022-2028)

    • Figure Japan Gene Therapies for Cancer Treatment Consumption Forecast and Growth Rate (2022-2028)

    • Figure India Gene Therapies for Cancer Treatment Consumption Forecast and Growth Rate (2022-2028)

    • Figure South Korea Gene Therapies for Cancer Treatment Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Type 1 Consumption and Growth Rate (2017-2022)

    • Figure Global Type 2 Consumption and Growth Rate (2017-2022)

    • Figure Global Type 3 Consumption and Growth Rate (2017-2022)

    • Figure Global Application 1 Consumption and Growth Rate (2017-2022)

    • Figure Global Application 2 Consumption and Growth Rate (2017-2022)

    • Figure Global Application 3 Consumption and Growth Rate (2017-2022)

    • Figure Global Type 1 Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Type 2 Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Type 3 Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Application 1 Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Application 2 Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Application 3 Consumption Forecast and Growth Rate (2022-2028)

    • Table Global Gene Therapies for Cancer Treatment Import by Region (Top 5 Countries) (2017-2028)

    • Table Global Gene Therapies for Cancer Treatment Export by Region (Top 5 Countries) (2017-2028)

    • Table Company 1 (Foundation Year, Company Profile and etc.)

    • Table Company 1 Gene Therapies for Cancer Treatment Sales, Price, Value and Gross Profit (2017-2022)

    • Table Company 1 Gene Therapies for Cancer Treatment Product and Service

    • Table Company 2 (Foundation Year, Company Profile and etc.)

    • Table Company 2 Gene Therapies for Cancer Treatment Sales, Price, Value and Gross Profit (2017-2022)

    • Table Company 2 Gene Therapies for Cancer Treatment Product and Service

    • Table Company 3 (Foundation Year, Company Profile and etc.)

    • Table Company 3 Gene Therapies for Cancer Treatment Sales, Price, Value and Gross Profit (2017-2022)

    • Table Company 3 Gene Therapies for Cancer Treatment Product and Service

    • Table Company 4 (Foundation Year, Company Profile and etc.)

    • Table Company 4 Gene Therapies for Cancer Treatment Sales, Price, Value and Gross Profit (2017-2022)

    • Table Company 4 Gene Therapies for Cancer Treatment Product and Service

    • Table Company 5 (Foundation Year, Company Profile and etc.)

    • Table Company 5 Gene Therapies for Cancer Treatment Sales, Price, Value and Gross Profit (2017-2022)

    • Table Company 5 Gene Therapies for Cancer Treatment Product and Service

    • Table Company 6 (Foundation Year, Company Profile and etc.)

    • Table Company 6 Gene Therapies for Cancer Treatment Sales, Price, Value and Gross Profit (2017-2022)

    • Table Company 6 Gene Therapies for Cancer Treatment Product and Service

    • Table Company 7 (Foundation Year, Company Profile and etc.)

    • Table Company 7 Gene Therapies for Cancer Treatment Sales, Price, Value and Gross Profit (2017-2022)

    • Table Company 7 Gene Therapies for Cancer Treatment Product and Service

    • Table Company 8 (Foundation Year, Company Profile and etc.)

    • Table Company 8 Gene Therapies for Cancer Treatment Sales, Price, Value and Gross Profit (2017-2022)

    • Table Company 8 Gene Therapies for Cancer Treatment Product and Service

    • Table Company 9 (Foundation Year, Company Profile and etc.)

    • Table Company 9 Gene Therapies for Cancer Treatment Sales, Price, Value and Gross Profit (2017-2022)

    • Table Company 9 Gene Therapies for Cancer Treatment Product and Service

    • Table Company 10 (Foundation Year, Company Profile and etc.)

    • Table Company 10 Gene Therapies for Cancer Treatment Sales, Price, Value and Gross Profit (2017-2022)

    • Table Company 10 Gene Therapies for Cancer Treatment Product and Service


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.